Hunan Jiudian Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hunan Jiudian Pharmaceutical Co., Ltd. was established in Liuyang Economic and Technological Development Zone in 2001. It is a modern listed pharmaceutical enterprise with a comprehensive layout in the fields of chemical pharmaceutical preparations, raw materials, pharmaceutical excipients, traditional Chinese medicine, and health food. The company has a high-quality R&D and technical team of more than 430 people, as well as advanced instruments and equipment. It has established national enterprise technology center, postdoctoral research workstation, new gel paste engineering research center in Hunan Province, respiratory drug engineering technology research center in Hunan Province and other innovation platforms. The company's leading products are all independently researched and developed, with unique characteristics in fields such as antipyretic and analgesic, cardiovascular and cerebrovascular, anti infection, digestion and metabolism, respiratory and anti allergic, traditional Chinese medicine, etc. The synthesis technology of various raw materials and excipients, as well as the research and production of topical patches, have taken a leading position in China, and have cultivated a gold variety with annual sales exceeding 1.3 billion yuan in the field of percutaneous drug delivery in China. After 22 years of establishment, the company has formed a development layout of "three parks in one", including Liuyang Preparation Park, Wangcheng API and Pharmaceutical Auxiliary Materials Park, and Lugu R&D and Office Park. The products cover the national market, and the raw and auxiliary materials products are exported to more than 60 countries and regions in Europe and America. Adhering to the core concept of "Nine Transformations of Chinese and Western Pharmacopoeia for Health" and adhering to the product strategy of "high-tech, new products, and patented drugs", the company is striving to become a leading enterprise in the field of percutaneous drug delivery in China, continuously advancing towards the goal of being one of the leaders in the Chinese pharmaceutical industry, and continuously striving to help build a healthy China. |
| Headquarter | Changsha |
| Establish Date | 1/19/2001 |
| Listed Code | 300705.SZ |
| Listed Date | 10/10/2017 |
| Chairman | Zhu Zhihong. |
| CEO | Zheng Xiahui. |
| Website | www.hnjiudian.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
